Showing results (1-10 of 2,971) with videos related to

Sort By:
Pageof 298
The Journal of Biological Chemistry|October 24, 1998
Steroid receptor coactivator-1 interacts with serum response factor and coactivates serum response element-mediated transactivationsH J Kim, J H Kim, J W Lee
Research Communications in Molecular Pathology and Pharmacology|April 1, 1999
Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in ratsJ Kim, K S Han, J W Lee, et al.
Molecular Endocrinology (Baltimore, Md.)|November 7, 1999
Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53S K Lee, H J Kim, J W Kim, et al.
Research Communications in Molecular Pathology and Pharmacology|January 14, 2000
Stability, blood partition, and protein binding of NQ12, a new naphthoquinone derivativeS H Kim, H J Kim, C K Ryu, et al.
Research Communications in Molecular Pathology and Pharmacology|January 1, 1996
Metabolic changes of acetaminophen after intravenous administration to rats pretreated with a hepatoprotective agent, YH-439E Cho, S H Jang, J W Lee, et al.
Molecular Endocrinology (Baltimore, Md.)|July 11, 1998
Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and TIF2H J Kim, S K Lee, S Y Na, et al.
The Bone & Joint Journal|March 29, 2018
Predictors of compartment syndrome of the foot after fracture of the calcaneusY H Park, J W Lee, J Y Hong, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 29, 1997
Determination of a new proton pump inhibitor, YH1885, in human plasma and urine by high-performance liquid chromatographyK S Han, H C Choi, J K Yoo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 1998
Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogsW H Yoon, J K Yoo, J W Lee, et al.
Biopharmaceutics & Drug Disposition|December 5, 1998
Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in ratsK S Han, Y G Kim, J K Yoo, et al.
Pageof 298